95. Design and Synthesis of Potent Macrocyclic Benzolactam Growth Hormone Secretagogues

  • Robert J. DeVita
  • , Alison J. Frontier
  • , William R. Schoen
  • , Matthew J. Wyvratt
  • , Michael H. Fisher
  • , Kang Cheng
  • , Wanda W.S. Chan
  • , Bridget S. Butler
  • , Roy G. Smith

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

The synthesis of a variety of potent macrocyclic growth hormone secretagogues, i.e. 5, 9, 12, and 20-22, based on the known lead structure L-692,429 (1) is described. These conformationally constrained growth hormone secretagogues were prepared by joining the two essential pharmacophores, the amino-acid side chain at the 1H-1-benzazepine moiety and the 1,1′-biphenyl moiety with a variety of linkers. The most potent analog was found to be L-744,080 (21), a derivative in which a 2′-carboxamide moiety at 1,1′-biphenyl is N,O-joined to the OH group of the (2-hydroxypropyl)amino-acid side chain by a C4 ester linker. This potent analog may be useful in determining the bound conformation of the benzolactam class of growth hormone secretagogues at the newly identified GHS receptor. L-744,080 (21) with an ED50 of 20 nM was up to fifty times more potent than the seco-acid precursor and 3-fold more potent than the parent 2′-tetrazole compound L-692,429 (1).

Original languageEnglish
Pages (from-to)1244-1259
Number of pages16
JournalHelvetica Chimica Acta
Volume80
Issue number4
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Dive into the research topics of '95. Design and Synthesis of Potent Macrocyclic Benzolactam Growth Hormone Secretagogues'. Together they form a unique fingerprint.

Cite this